Navigation Links
InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac, an Animal Free Reagent for Bacterial Fermentation
Date:11/10/2009

InVitria's Lysobac is a high potency, animal free and consistent alternative to chicken lysozyme, which is used in bacterial cell lysis. Tests prove Lysobac is greater than 4 times more active than chicken lysozyme and increases protein yield from bacterial fermentation.

Fort Collins, CO (PRWEB) November 10, 2009 -- Manufactured in an animal free production system, InVitria's Lysobac is a cost-effective, more consistent and performance enhancing alternative to chicken lysozyme, also called hen egg white lysozyme (HEWL).

Now, InVitria will meet the demand of large commercial users who require metric ton quantities of bacterial cell lysis reagents. "With the increase in production capacity at our ISO 9001 facility, we now have the ability to supply large volumes of Lysobac to commercial customers all over the world," said Greg Unruh, Vice President of Production.

"InVitria customers have achieved significant performance and safety benefits from using Lysobac as a cell lysis reagent," said Scott Deeter, President and CEO. "Further, Lysobac allows manufacturers to switch to an animal free production system and avoid the risk of contaminants from animal derived components," said Deeter.

Lysobac offers substantial advantages over chicken lysozyme and mechanical lysis, including:

 
  • Animal free
  • Greater than 4x more active than chicken lysozyme (units/mg protein)
  • Delivers more recombinant protein yield
  • Consistent from lot-to-lot
  • Improves bioprocessing efficiency
  • Reduces overall production costs

Through December 1, 2009, InVitria is offering a FREE Papa John's Pizza gift card for all Lysobac orders placed through InVitria's WebStore. Visit Lysobac Online to place your order.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media and bacterial cell lysis supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's products, please contact InVitria's Product Support team at info@invitria.com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/BacterialFermentation/chickenlysozymeHEWL/prweb3182554.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria to Present at WilBio's International Cell Engineering Meeting
2. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
3. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
4. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
5. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
6. InVitria Announces Launch of Recombinant Albumin for Diagnostics
7. InVitria Headlines Sponsorship of WilBio's Waterside Conference
8. InVitria Reveals Technology to Optimize Hybridoma Production Performance
9. InVitria to Present at BIO 2009 International Convention in Atlanta
10. InVitria Sponsors ESACT 2009 in Dublin, Ireland
11. InVitria Cell Culture Product Line to Headline PEACe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)...  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: